Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs GraniteShares 2x Long NVDA Daily ETF (NVDL) Price & Performance

Cassava Sciences IncTrade
GraniteShares 2x Long NVDA Daily ETFTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while GraniteShares 2x Long NVDA Daily ETF trades at $36.86 (market cap $3.56B). The key difference: GraniteShares 2x Long NVDA Daily ETF is far larger — about 90.4× Cassava Sciences Inc's market cap, and GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.

FLNANVDL
Market Cap
$39.40M$3.56B
Volume
759,0189,740,643
Sector
HealthLeveraged / Inverse
52-Week High
$4.64$43.02
52-Week Low
$0.68$21.76
Typical Hold Time
37 Days15 Days
Enterprise Value
-$43.28M—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.8136, down 0.26% with a bearish technical signal. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent positive FDA news regarding the clinical hold lift on simufilam for epilepsy research provides a potential catalyst. Cash flow remains negative with net cash flow of -$33.07M in 2025.

The outlook is mixed with strong analyst support (66.7% buy ratings) against fundamental challenges. Investment opportunity lies in clinical trial success, while risks include sustained cash burn and execution hurdles. The stock's low EV/EBITDA of 1.03 and P/B of 0.62 suggest undervaluation if pipeline milestones are met.

GraniteShares 2x Long NVDA Daily ETF

NVDL (GraniteShares 2x Long NVDA Daily ETF) trades at $37.28, down 5.79% in the last session. Technical indicators show a bullish bias with moving averages supporting upward momentum while oscillators remain neutral. The ETF provides 2x daily leveraged exposure to NVIDIA, which continues to dominate AI chip markets with strong earnings performance. Recent news highlights ongoing M&A activity in the ETF space and continued AI sector strength.

The outlook remains positive given NVIDIA's market leadership and AI growth trajectory, though leveraged ETF structure introduces volatility risks. Key opportunities include continued AI adoption and NVIDIA's execution, while risks involve leverage decay and sector concentration. Current technical setup suggests potential for recovery toward resistance levels near $39-41 if bullish momentum resumes.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA
47% Buy53% Sell
Avg holding period · 37 Days
NVDL
100% Buy0% Sell
Avg holding period · 15 Days

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →

About GraniteShares 2x Long NVDA Daily ETF

NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.

Read more on NVDL →